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ABSTRACT Nephrotic syndrome (NS) is character-
ized by structural changes in the actin-rich foot pro-
cesses of glomerular podocytes. We previously identi-
fied high concentrations of the small heat shock protein
hsp27 within podocytes as well as increased glomerular
accumulation and phosphorylation of hsp27 in puromy-
cin aminonucleoside (PAN) -induced experimental NS.
Here we analyzed murine podocytes stably transfected
with hsp27 sense, antisense, and vector control con-
structs using a newly developed in vitro PAN model
system. Cell morphology and the microfilament struc-
ture of untreated sense and antisense transfectants
were altered compared with controls. Vector cell sur-
vival, polymerized actin content, cell area, and hsp27
content increased after 1.25 g/ml PAN treatment and
decreased after 5.0 g/ml treatment. In contrast, sense
cells were unaffected by 1.25 g/ml PAN treatment
whereas antisense cells showed decreases or no changes
in all parameters. Treatment of sense cells with 5.0
g/ml PAN resulted in increased cell survival and cell
area whereas antisense cells underwent significant de-
creases in all parameters. Hsp27 provided dramatic
protection against PAN-induced microfilament disrup-
tion in sense > vector > antisense cells. We conclude
that hsp27 is able to regulate both the morphological
and actin cytoskeletal response of podocytes in an in
vitro model of podocyte injury.—Smoyer, W. E., Ran-
som, R. F. Hsp27 regulates podocyte cytoskeletal
changes in an in vitro model of podocyte process
retraction. FASEB J. 16, 315–326 (2002)
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Nephrotic syndrome (NS) is among the most com-
mon kidney diseases in children and frequently occurs
in adults. In this disease, the kidney’s filtration barrier
is altered to permit massive amounts of protein to be
lost in the urine, leading to low oncotic pressure in
serum and resultant leakage of fluid from the blood-
stream into the surrounding tissues as edema. These
clinical findings correlate with dramatic structural al-
terations in glomerular epithelial cells (podocytes),
which together with the underlying glomerular base-
ment membrane (GBM) and endothelial cells com-
prise the kidney’s filtration barrier. These structural
changes include retraction and effacement (spreading)
of the podocyte distal foot processes overlying the
GBM, disruption and redistribution of the dense accu-
mulations of actin within these processes, and in some
areas detachment of podocytes from the GBM (1–5).
The pathological mechanisms leading to NS are
diverse, including immunological processes, biochemi-
cal or genetic defects, and hemodynamically induced
glomerular injury (6). However, common histological
features are observed in each setting, suggesting that a
shared molecular mechanism mediates the podocyte
structural changes characteristic of NS. One of the
primary structural alterations shown to be common to
both human disease and animal models of NS is the
disruption of the podocyte cytoskeleton, with marked
disaggregation and redistribution of actin filaments in
the podocyte foot processes (7–9). Actin filaments have
been reported to be the major or sole cytoskeletal
protein in podocyte foot processes (10, 11), which
suggests that the podocyte actin cytoskeleton may play
a critical role in the regulation of foot process structure
and function in both health and disease.
We previously reported the presence of high concen-
trations of the small heat shock protein hsp27 in the
glomeruli of normal rats, as well as an increase in
glomerular hsp27 and phosphorylation after induction
of experimental NS with puromycin aminonucleoside
(PAN) (12). Although the precise mechanism(s) of
action of hsp27 is not yet known, it is a small stress
protein reported to have important roles in resistance
to thermal and metabolic stress, normal growth and
differentiation, signal transduction, molecular chaper-
oning, and protection from apoptosis (13–20). Perhaps
its best-described function, however, is that of a regu-
lator of actin polymerization. Hsp27 has been reported
to be an actin-associated protein (21) that was shown to
inhibit actin polymerization in vitro (22) and in vivo
(23), and its ability to inhibit actin polymerization
has been correlated with its state of phosphorylation
(15, 24).
Based on these findings we hypothesized that hsp27,
via regulation of the actin cytoskeleton, has an impor-
tant role in regulating both normal podocyte structure
and the dramatic structural changes in podocytes that
occur during NS. To begin to test this hypothesis, we
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developed a model of low-concentration (10 g/ml)
and long-term (7 days) treatment of cultured ‘differen-
tiated’ podocytes with the well-described podocyte
toxin PAN, followed by quantitative analyses of changes
in podocyte cell survival, morphology, cell area, actin
filament structure, and total filamentous actin (F-actin)
content. This model was then used to quantitatively
determine the specific effects of altered podocyte
hsp27 levels on the podocyte response to PAN.
MATERIALS AND METHODS
Cell culture
A conditionally immortalized mouse podocyte clonal cell line
(MPC-5) isolated from the ‘Immortomouse’ (25) was a kind
gift from Dr. Peter Mundel. Proliferating podocyte cells were
grown in RPMI 1640 medium containing 10% fetal bovine
serum, 100 U/ml penicillin, 100 g/ml streptomycin (Gibco-
BRL, Rockville, MD), and 10 U/ml mouse -interferon
(Sigma, St. Louis MO) at 33°C with 100% relative humidity
and 5% CO2 atmosphere. Cells were induced to differentiate
by transfer to 37°C and removal of -interferon from the
above medium to deactivate the transgene for a thermosen-
sitive variant of the SV40 T-antigen. All cultured podocytes
used in this study were allowed to differentiate without
subcultivation for 10–14 days before treatment. Twice as
many antisense transfectant cells were seeded in culture
dishes (72,000 cells/well in 6-well dish) for differentiation
than vector control or sense transfectants (36,000 cells/well)
in order to yield differentiated cultures with similar cell
confluence at 10–14 days.
NIH 3T3 cells (ATCC #CRL-1658, ATCC, Manassas, VA)
and murine mesangial cells (MMC; a kind gift from Dr.
Hanna Abboud) were grown in Dulbecco’s modified Eagle’s
medium (Gibco-BRL) containing either 10% bovine calf
serum (NIH-3T3) or fetal bovine serum (MMC) and 100
U/ml penicillin and 100 g/ml streptomycin at 37°C with
100% relative humidity and 5% CO2 atmosphere. Cells were
seeded at 20,000 cells/well of a 6-well culture dish and treated
with PAN after 24 h in culture.
Development of stably transfected podocyte clones
Proliferating podocytes were transfected with human hsp27
sense (26), rat hsp27 antisense (27), and vector control cDNA
(pcDNA3.1, Stratagene, La Jolla, CA) constructs using a
transfection reagent (Superfect, Quiagen, Valencia, CA) ac-
cording to the manufacturer’s instructions. Stably transfected
cells were selected in serial passages using G418 antibiotic at
400 g/ml (100% lethal to untransfected podocytes). The
expression vectors contained the entire protein coding re-
gion of human hsp27 placed in the sense orientation or the
entire protein coding region of rat hsp27 in the antisense
orientation, both inserted in the mammalian expression
vector pcDNA3.1 under the control of the constitutive cyto-
megalovirus promoter. Clonal populations of stably trans-
fected hsp27 sense or antisense podocyte clones were isolated
by limiting dilution and selected for altered hsp27 levels.
Stably transfected clones were then induced to differentiate
as described above in the presence of a reduced concentra-
tion (200 g/ml) of G418. Before treatment with PAN, cells
were transferred to medium without G418.
In vitro model of podocyte process retraction
Differentiated podocyte clones were treated with a single
application of PAN (Sigma) to a final concentration of 1.25 or
5.0 g/ml. Controls received an equivalent volume of sterile
water. Cells were cultured for an additional 7 days without
subcultivation. Subconfluent MMC and NIH-3T3 cells were
similarly treated with PAN at concentrations identical to or
markedly higher than those for podocytes. Because, in con-
trast to differentiated podocyte cultures, both MMC and
NIH-3T3 cells proliferate continuously in culture, cells were
seeded at low density and cultured for 7 days in the presence
of PAN.
Phase contrast microscopy
Phase contrast microscopy was performed as described previ-
ously (28) on an inverted Zeiss Axiovert 135TV using a 20
objective lens, an 0.55 NA long-working distance condenser
lens, and phase contrast optics. Images were acquired using a
monochrome CCD camera (Dage model RT3000) driven by
NIH Image 1.61 software and captured using a Scion LG3
image capture board installed in an Apple Macintosh com-
puter (PowerPC 7500). Images were adjusted for contrast and
gain in Adobe Photoshop v. 5.0.2.
Immunohistochemistry
After PAN treatment for 7 days, cells grown on glass coverslips
were washed briefly in warm PBS and fixed in 3.7% parafor-
maldehyde in PBS for 30 min. Cells were lysed by addition of
an equal volume of 0.5% Triton X-100 in PBS to the fixation
solution and incubation for another 5 min. Cells were washed
with 0.05% Tween-20 in PBS (T-PBS) and incubated with
Texas red-conjugated phalloidin (Molecular Probes, Eugene,
OR) diluted 1:250 in 5% heat-inactivated horse serum in
T-PBS for 30 min. Coverslips were washed and mounted in
0.05% phenylenediamine in 90% glycerol in PBS and sealed
with fingernail polish. Fluorescence microscopy was per-
formed as described previously (28). Prepared cells were
imaged on an inverted Zeiss Axiovert 135TV with an AtoArc
100W epifluorescent illuminator and 20 objective lens.
Images were collected using an integrating monochrome
CCD camera (Dage model RT3000) driven by NIH Image
1.61 software (with capture hardware described above) using
macros permitting collection and signal averaging over sev-
eral video frames. An average of 16 frames were integrated for
fluorescent images. Images were adjusted for contrast and
gain, and levels were adjusted in Adobe Photoshop v. 5.0.2.
All immunofluorescence micrographs shown were taken of
one of the two clones of hsp27 sense (clone 23) and hsp27
antisense (clone 9) cells, but were representative of results
gathered for both clonal lines of each type.
Phalloidin binding assay
Phalloidin binding was determined using a modification of
the protocol of Singhal et al. (29). After treatment, cells were
washed briefly in warm PBS and fixed in 3.7% paraformalde-
hyde in PBS for 30 min. Fixed cells were washed once with
PBS and incubated in 0.1% saponin in PBS containing a
saturating amount (0.4 M) of Texas red phalloidin for 1 h at
room temperature in darkness with gentle agitation. Cells
were washed twice with 0.1% saponin in PBS and the labeled
phalloidin was extracted from cells into 1 ml methanol by
agitation for 30 min in darkness. The methanol was collected,
centrifuged at 14,000 g for 5 min and supernatant fluores-
cence was measured in an LS-50B luminescence spectrometer
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(Perkin Elmer Analytical Instruments, Norwalk, CT) with
excitation at 591 nm and emission measured at 608 nm.
Linear regression analyses of Texas red phalloidin standards
was used to derive absolute amounts of bound phalloidin
from each sample’s relative fluorescence values. Protein was
extracted from duplicate wells and assayed by the bicincho-
ninic acid (BCA) microassay (see below); these values were
used to normalize the amount of bound phalloidin to protein
quantity.
Cell survival assay
After PAN or sham treatment, culture medium was collected
and the adherent cells were collected by trypsinization. The
cells suspended in trypsin solution were combined with the
original culture medium and cells were pelleted by centrifu-
gation at 1500 g for 3 min. The cells were resuspended in PBS
and an equal volume of 0.4% trypan blue in PBS was added.
After 1 min, two aliquots of each cell suspension were
counted using a hemocytometer. Cells that freely took up dye
(deep blue) were scored as dead, and pale blue or clear cells
were scored as live.
Cell area determination
Phase contrast micrographs (n6) were collected randomly
from fixed cells after PAN treatment. The 10 cells in each
digital micrograph that were entirely within the image field
and closest to the arbitrary upper right-hand corner of the
image were hand-traced using a graphics tablet (WACOM,
Vancouver, WA) and NIH Image 1.61 software. Measure-
ments were made of the total number of pixels within each
outline and converted to unit area using a conversion factor
derived from pixel measurements of a standard measure
using the same microscopic optics arrangements.
Protein extraction
Proteins were extracted from cell cultures by washing adher-
ent cells with warm PBS, followed by addition of 1 ml per well
of a 6-well tissue culture plate of 1:1 water-saturated phenol:
extraction buffer. The extraction buffer consisted of 50 mM
tris-Cl pH 7.0, 700 mM sucrose, 50 mM KCl, 100 mM NaF, 2
mM each of MgCl2, EGTA, and 2-mercaptoethanol, 1 mM
sodium orthovanadate, and 0.1 mM PMSF. Cells were ex-
tracted for 5 min at room temperature and the extracts
centrifuged at 1500 g for 15 min at 10°C to separate phases.
The upper, phenol phase was removed and mixed with 5 vol
of 20°C methanol acidified with 100 mM ammonium ace-
tate. After precipitation of protein overnight at 20°C, pre-
cipitates were collected by centrifugation at 1500 g for 25 min
at 4°C. Pellets were washed twice with ice-cold 80% methanol
and dried under vacuum. Protein was solubilized from dried
pellets in a minimal volume of 2% SDS, 62.5 mM tris-Cl pH
6.8, 10% glycerol for SDS-PAGE analysis or into isoelectric
focusing (IEF) sample buffer (9 M urea, 2% (w/v) Nonidet
P-40, 50 mM NaF, 5 mM sodium orthophosphate, 67 mM
[-D] glycerophosphate pH 7.2, 1 mM sodium orthovana-
date, 1 mM EDTA, 2% 2-mercaptoethanol, 0.1 mM PMSF,
and 0.5 g/ml each of leupeptin, pepstatin, and aprotinin)
by prolonged, gentle agitation. The protein content in SDS-
PAGE samples was determined using the BCA microassay.
SDS-PAGE, slab IEF separations, and Western blotting
SDS-PAGE sample buffer extracts containing equal quantities
of protein from each sample were brought to 5% 2-mercap-
toethanol, heated to 100°C for 4 min, and separated on 13%
polyacrylamide gels by SDS-PAGE, followed by transfer to
PVDF membranes by immersion blotting. Urea buffer protein
extracts containing similar amounts of hsp27 (as determined
by prior analysis of SDS-PAGE sample buffer extracts by
quantitative Western blotting) were separated by slab-gel IEF
using the Bio-Rad Model 111 Mini-IEF Cell essentially accord-
ing to the manufacturer’s instructions, except that the sup-
port film was omitted to permit subsequent transfer of
proteins to PVDF membranes. Proteins were focused at 100 V
for 15 min, 200 V for 15 min, and finally at 450 V for 1 to 2 h.
After focusing, proteins were transferred to PVDF mem-
branes by semi-dry transfer for 30 min at 75 mA.
Protein binding sites on PVDF membranes were blocked
with 5% nonfat dry milk in T-PBS overnight at 4°C. Mem-
branes were incubated with primary antibodies [1:5000 rabbit
anti-murine hsp27 polyclonal or mouse anti-human hsp27
monoclonal (StressGen, Victoria, BC, Canada)] in 5% BSA in
T-PBS for 1 h at room temperature. After three washes, blots
were incubated in secondary antibody solution [1:10,000 goat
anti-rabbit IgG horseradish-peroxidase conjugate or 1:5000
goat anti-mouse IgG horseradish-peroxidase conjugate (Jack-
son ImmunoResearch, West Grove, PA)] in 5% nonfat dry
milk in PBS-T for 1 h at room temperature. After three
additional washes, antibody binding was visualized using the
ECL chemiluminescence system (Amersham, Arlington
Heights, IL) as detected using the Bio-Rad Chemidoc system
(Bio-Rad, Hercules, CA). Densitometric analyses of captured
images were performed using version 4.1.0.026 of the Bio-Rad
Quantity One software. Quantitation of the absolute amounts
of specific protein in each band was performed by linear
regression analysis using six different amounts of standard
protein (murine or human hsp27; StressGen) on each blot to
generate standard curves of protein content vs. densitometric
units (mean density value  area).
Protein assay
The BCA protein microassay (30) was used to quantify total
protein in samples. Equal volumes of sample solubilization
buffer were added to albumin protein standards to normalize
for the effect of buffer components on the assay results.
Statistics
Results were analyzed for statistical significance using Statview
v. 4.57 software (Abacus Concepts, Berkeley, CA) by the
unpaired, two-tailed t test. Comparisons with P values  0.05
were considered significant and P values  0.01 were sepa-
rately noted. Separate statistical analyses were performed to
compare PAN-treated vs. sham-treated individual transfectant
clones (*P0.05 and **P0.01 vs. sham-treated cells) and to
compare PAN-treated and sham-treated vector control cells
with the combined results from both clones of similarly
treated hsp27 sense or antisense transfectants (P0.05,
P0.01 vs. vector cells).
RESULTS
Podocyte treatment with PAN induces variable
Hsp27 accumulation
Protein extracts from untransfected podocytes differen-
tiated for 10–14 days followed by PAN treatment for 7
days were analyzed by quantitative Western blotting
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using an anti-murine hsp27 antibody. Podocytes treated
with a low dose of PAN (1.25 g/ml) had a significant
accumulation of hsp27 (230	13% of hsp27 content in
time-matched, sham-treated control cells) and podo-
cytes treated with high-dose PAN (5.0 g/ml) had a
significant decline in hsp27 content (20	4% of control
hsp27 value). These findings demonstrated that low-
dose PAN treatment induces accumulation of endoge-
nous hsp27 in cultured podocytes and are consistent
with our previously reported findings of hsp27 accumu-
lation in glomeruli after PAN-induced NS in animals
(12).
Stable podocyte transfectants contain dramatically
different amounts of Hsp27
Protein extracts of independently cloned podocyte cell
lines stably transfected with either human hsp27 sense
(sense) or rat hsp27 antisense (antisense) constructs
and differentiated for 10 days were analyzed by quan-
titative Western blotting using anti-human hsp27 or
anti-murine hsp27 antibodies. These reagents allowed
independent analysis of the human or murine hsp27
isoforms without interspecies cross-reaction. Vector
control podocytes contained 2.34 ng of murine
hsp27/g protein (Fig. 1) and, as expected, no detect-
able human hsp27 (data not shown). Both sense clones
had significantly greater amounts of human hsp27
(17.1 and 14.9 ng hsp27/g protein in clones 23 and
31, respectively) than the amount of murine hsp27 in
vector controls whereas both antisense clones con-
tained significantly smaller amounts of murine hsp27
(0.41 and 0.21 ng hsp27/g protein in clones 9 and 20,
respectively) than vector-transfected cells (Fig. 1). No
endogenous murine hsp27 protein was detected (limit
of detection 
0.02 ng/g protein) in sense clones
(data not shown). The mean amount of hsp27 present
in all sense clones combined was  680% of vector
control values whereas the mean quantity of hsp27 in
antisense clones was only 13% of vector control values,
equivalent to a 51-fold difference in hsp27 expression
between sense and antisense clones.
Stable podocyte transfectants have less Hsp27
phosphorylation than vector transfectants
Protein extracts from differentiated vector control cells
or sense or antisense clones were separated by IEF,
followed by Western blotting to determine the relative
amount of hsp27 phosphorylation. Only monophos-
phorylated and unphosphorylated hsp27 isoforms were
detected in extracts of transfectants, despite two possi-
ble serine phosphorylation sites on murine hsp27 and
three possible sites on human hsp27 (31). The percent-
age of hsp27 phosphorylated was greater in vector
control cells (30%) than in antisense clone 9 (21%) or
in either of the sense clones (13% and 17% in clones 23
and 31, respectively), as shown in Fig. 2. When the
results from individual clones were combined and
analyzed in aggregate, there was significantly more
phosphorylated hsp27 in vector cells than in either
antisense or sense clones. Aggregate significance values
were determined by comparing vector values (n4,
mean30%) with combined antisense (n8, four each
of clones 9 and 20, mean23%) or sense (n8, four
each of clones 23 and 31, mean15%) values. These
results demonstrated that in murine podocyte transfec-
tants, both the endogenous murine hsp27 in vector and
antisense transfectants and the exogenous human
hsp27 in sense transfectants are phosphorylated.
Because the absolute amounts of phosphorylated
and unphosphorylated hsp27 present in cells may be
more biologically relevant than percentage of phos-
phorylated hsp27, absolute quantities of phosphory-
lated and unphosphorylated hsp27 (Table 1) in each
podocyte clone were calculated from the data shown in
Figs. 1 and 2. This analysis revealed that although a
smaller percentage of the hsp27 in sense clones was
phosphorylated than in vector controls (Fig. 2), the
absolute amount of phosphorylated hsp27 in sense cells
was  threefold greater than the amount in vector
Figure 1. Stable podocyte transfectants express markedly
different amounts of hsp27. The results of quantitative West-
ern blotting analyses for murine or human hsp27 in differen-
tiated podocyte clones transfected with vector alone, human
hsp27 sense, and rat hsp27 antisense constructs are shown.
Both sense clones (dark gray bars) and both antisense clones
(light gray bars) expressed significantly different amounts of
hsp27 than vector controls (hatched bar). Percentage values
express the amount of human hsp27 in sense clones or
murine hsp27 in antisense clones as a percentage of the
amount of murine hsp27 in vector controls. No murine hsp27
was detected in human sense clones; as expected, no human
hsp27 was detected in vector or hsp27 antisense clones (data
not shown) (n4; x	se;P0.001 vs. vector control cells).
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controls (2.2 ng/g vs. 0.7 ng/g; Table 1). In
contrast, both the percentage and absolute amount of
phosphorylated hsp27 in antisense clones were less
than the corresponding values in vector controls (Fig. 2
and Table 1). Similarly, the amount of unphosphory-
lated hsp27 in sense transfectants was  sixfold greater
than the amount in vector controls and 
sixfold more
unphosphorylated hsp27 was present in vector controls
than in antisense clones. The finding that a smaller
percentage but larger absolute amount of hsp27 is
phosphorylated in sense transfectant clones vs. vector
controls and that there is a larger absolute amount of
unphosphorylated hsp27 in sense (and lesser amount
in antisense) than vector controls raises the possibility
that the observed phenotypic differences between
transfectants and controls (see below) may be due to
differences in either the amount of total hsp27 (Fig. 1)
or the amount of a particular phosphorylated isoform
of hsp27 (Table 1).
Hsp27 regulates normal podocyte morphology and
PAN-induced morphological changes
Differentiated sense and antisense clones displayed
dramatically different cellular morphologies compared
with vector controls as examined by phase contrast
microscopy (Fig. 3). Untreated, differentiated vector
control cells displayed a characteristic flattened mor-
phology with numerous cell processes (Fig. 3A)
whereas untreated sense clones were often elongated,
with smooth cell borders and many contiguous areas of
cell–cell contact (Fig. 3D); antisense clones were flat-
tened but exhibited less frequent and smaller processes
than controls (Fig. 3G).
Vector and sense cell morphology was largely un-
changed after treatment with 1.25 g/ml PAN (Fig. 3B,
E) whereas many antisense cells had partially retracted
and some cells had detached (Fig. 3H). After treatment
with 5.0 g/ml PAN, the majority of attached vector
and antisense cells retracted (Fig. 3C, I) and the vast
majority of antisense cells detached and died (data not
shown). In marked contrast, sense cells (Fig. 3F) dis-
played relative morphological preservation after PAN
treatment vs. either vector control (Fig. 3C) or anti-
sense (Fig. 3I) cells. These results indicated that hsp27
was able to both alter normal podocyte morphology
and modulate PAN-induced podocyte morphological
changes.
Hsp27 regulates podocyte cell survival after
PAN treatment
Trypan blue assays after treatment revealed there were
no significant differences in the number of nonvital
cells (cells that took up dye) either between vector
control, sense, and antisense transfectants or between
untreated and PAN-treated cells. In all cell suspensions
regardless of hsp27 protein expression or treatment,

10% of cells were dead (data not shown). Cell counts
of living cells, however, showed that stable transfection
and PAN treatment both influenced the number of
vital cells remaining in podocyte cultures after differ-
entiation and treatment. Approximately half of the
number of vector control cells initially seeded into
plates (3.6104) were present after differentiation and
sham treatment (1.8104, Fig. 4A, left bar). There were
significantly more live vector cells present in cultures
treated with 1.25 g/ml PAN than in untreated cul-
tures, but significantly fewer after treatment with 5.0
g/ml PAN (Fig. 4A). In contrast, the number of live
TABLE 1. Hsp27 phospho-isoforms in podocyte transfectantsa
Transfectant Unphosphorylatedb Monophosphorylatedc
Vector 1.67 0.70
Sense Clone 23 14.9 2.22
Sense Clone 31 12.4 2.53
Antisense Clone 9 0.32 0.09
Antisense Clone 20 0.16 0.05
a The absolute amount of un- or monophosphorylated hsp27 in
stably transfected, differentiated podocytes was derived from the
quantitation of total hsp27 (Fig. 1) and the percentage of phosphor-
ylated hsp27 (Fig. 2). b Nanograms of unphosphorylated
hsp27/g total cellular protein. c Nanograms of monophospho-
rylated hsp27/g total cellular protein.
Figure 2. Stable podocyte transfectants have less hsp27 phos-
phorylation than do vector transfectants. The results of IEF
separation and Western blot analyses of extracts from differ-
entiated podocyte clones transfected with vector alone, hsp27
sense, or hsp27 antisense constructs are expressed as %
phosphorylated hsp27 (ratio of monophosphorylated isoform
to total of phosphorylated and unphosphorylated hsp27
expressed as a percentage). The percentage of phosphory-
lated hsp27 in both sense clones (dark gray bars), singly and
in aggregate, was significantly less than the percentage of
phosphorylated hsp27 in vector control cells (hatched bar).
Similarly, the percentage of phosphorylated hsp27 in anti-
sense clone 9 and in the aggregate of both antisense clones
(light gray bars) was significantly less than vector values (n4;
x	se;P0.05, P0.001 vs. vector control cells).
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sense clone 31 cells increased significantly vs. untreated
sense cells at both PAN concentrations (Fig. 4B, right
bars) whereas the number of live sense clone 23 cells
increased significantly only after treatment with 5.0
g/ml PAN (Fig. 4B, left bars). In marked contrast to
sense clones and vector control cells, a significant
decline in the number of live antisense clone 20 cells
was observed after 1.25 g/ml PAN treatment (Fig. 4C,
right bars), and both antisense clone populations dra-
matically declined compared with untreated controls
after 5.0 g/ml PAN treatment.
When compared with identically treated vector con-
trol cells, the mean number of sense cells (results from
both clones in aggregate) was significantly greater in
sham-treated controls (mean of 2.8104 sense cells vs.
1.8104 vector control cells) and after PAN treatment
at either concentration (Fig. 4B vs. A). In contrast, even
though cultures were initially seeded with twice as many
antisense cells (7.2104), when considered in aggre-
gate there were no significant differences between
vector controls and antisense clones after sham treat-
ment or treatment with PAN at 1.25 g/ml (Fig. 4C vs.
A). Notably, however, the number of antisense cells
remaining after treatment with 5.0 g/ml PAN was
Figure 3. Hsp27 regulates nor-
mal podocyte morphology and
the morphological changes in-
duced by PAN. Phase contrast
micrographs of vector control
(A–C), hsp27 sense (D–F), and
hsp27 antisense (G–I) transfec-
tants are shown after treatment
for 7 days with 0 g/ml (A, D,
G), 1.25 g/ml (B, E, H), or 5.0
g/ml (C, F, I) PAN. Micro-
graphs of only one clone each
of sense (clone 23) or antisense
(clone 9) transfectants are shown,
but are representative of results
obtained with both clones. White
bar in lower right corner  40 .
Figure 4. Hsp27 regulates podocyte cell
survival after PAN treatment. Cell survival
determinations for differentiated podo-
cyte clones transfected with vector alone
(A), hsp27 sense (B; left barsclone 23,
right barsclone 31), or hsp27 antisense
(C; left barsclone 9, right barsclone
20) constructs are shown after treatment
for 7 days with 0, 1.25, or 5 g/ml PAN.
Vector control and sense clones were
seeded at 36,000 cells/well whereas twice
as many antisense clones were initially
seeded to result in a similar cell density
after differentiation. After differentiation
for 10 days, cells were treated for 7 days, trypsinized, and assayed for vitality with trypan blue yielding counts of live (excluded
dye) and dead cells. Only live cell counts are plotted, since 
10% of total cells were dead in each treatment (n3; x	se;
*P0.05, **P0.01 vs. untreated control cells; P0.05, P0.01 vs. vector control cells).
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significantly less than identically treated vector controls
(Fig. 4C vs. A). These results confirmed the ability of
hsp27 to influence podocyte cell survival during differ-
entiation as well as modulating the response to PAN
treatment.
Hsp27 regulates podocyte polymerized actin content
after PAN treatment
Since disruption of podocyte actin filaments is a char-
acteristic feature of NS and hsp27 is a known regulator
of actin polymerization, the amount of phalloidin
bound by podocytes was assayed to provide a quantita-
tive measure of the amount of polymerized actin
present in cells. We found a significant increase in the
polymerized actin content of vector cells after treat-
ment with 1.25 g/ml PAN vs. untreated controls and
a significant decrease after 5.0 g/ml PAN (Fig. 5A). In
contrast, there was no significant change in phalloidin
binding in either sense clone after PAN treatment
except for a slight decrease in sense clone 23 after
treatment at 5.0 g/ml (Fig. 5B, left bars), whereas
both antisense clones displayed a significant decrease
in phalloidin binding compared with untreated cells
after PAN treatment at both concentrations (Fig. 5C).
Combined phalloidin binding assay results from both
sense or both antisense clones in aggregate were also
compared with identically treated vector controls. After
treatment with 5.0 g/ml PAN, significantly more
phalloidin was bound by sense cells than vector con-
trols (Fig. 5B vs. A) whereas antisense cells bound less
phalloidin than vector controls after 1.25 (Fig. 5C vs. A)
and similar amounts after 5.0 g/ml PAN treatment.
Since phalloidin binding represents a measure of cel-
lular polymerized actin, these results indicated clearly
that sense clones were significantly more resistant to
PAN-induced disruption of podocyte actin filaments
than either vector control or antisense cells.
Hsp27 regulates both normal podocyte actin
cytoskeleton and the changes induced by PAN
Figure 6 shows representative micrographs of the
structure of actin filaments as revealed by fluorescent
phalloidin labeling in cells after differentiation and
PAN treatment. Untreated vector control cells (Fig.
6A) contained central, regular arrays of large actin
stress fibers surrounded by a peripheral region con-
taining mostly smaller actin filaments. Cellular pro-
cesses contained actin filaments, but not exclusively
in the form of large stress fibers. In contrast, un-
treated sense clones (Fig. 6D) contained abundant,
parallel arrays of comparatively thin actin stress fibers
that extended across the entire cell body. Untreated
antisense clones (Fig. 6G) contained a mixture of
large and smaller stress fibers, often with a central
bundle of large stress fibers and smaller peripheral
stress fibers.
After treatment with PAN at 1.25 g/ml, actin
filaments in vector control cells (Fig. 6B) were par-
tially disrupted, with large stress fibers spread more
diffusely than in untreated cells; strongly staining,
punctate concentrations of polymerized actin ap-
peared in cells. At the higher PAN concentration
(Fig. 6C), the large stress fibers had almost com-
pletely disappeared, though finer actin filaments
were still visible in the cell body, often arranged in a
circular pattern. The punctate actin concentrations
were more prominent than at 1.25 g/ml PAN. In
contrast to these changes, actin filaments in PAN-
treated sense clones were largely unaffected by PAN
treatment at either concentration (Fig. 6E, F), al-
though some subcortical and punctate concentra-
tions of polymerized actin were visible in sense cells
treated with 5.0 g/ml PAN (Fig. 6F). Compared
with either the vector control or sense clones, the
actin cytoskeleton in antisense clones was more se-
verely disrupted by PAN. Treatment with the lower
PAN dosage (1.25 g/ml) caused loss of most large
stress fibers (Fig. 6H). After treatment with 5.0
g/ml PAN (Fig. 6I), large stress fibers essentially
disappeared from the few remaining antisense cells,
leaving only a thin subcortical ring of polymerized
actin and fine actin filaments in the cell body. Similar
to the phalloidin binding results above, these results
clearly demonstrated that hsp27 was able to modu-
late PAN-induced disruption of podocyte actin fila-
ments.
Figure 5. Hsp27 regulates podocyte poly-
merized actin content after PAN treat-
ment. The results of phalloidin binding
assays as a quantitative, normalized mea-
sure of polymerized cellular actin (fmol
phalloidin bound per g of total protein)
are shown in differentiated podocyte
clones transfected with vector alone (A),
hsp27 sense (B; left barsclone 23, right
barsclone 31), and hsp27 antisense (C;
left barsclone 9, right barsclone 20)
constructs after treatment for 7 days with
0, 1.25, or 5 g/ml PAN. After differen-
tiation, cells were treated for 7 days with
PAN, fixed, and incubated with a saturating quantity of Texas red phalloidin. Bound phalloidin was extracted into methanol and
quantified by fluorescence spectroscopy (n3; x	se; *P0.05, **P0.01 vs. untreated control cells; P0.05, P0.01 vs.
vector control cells).
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Hsp27 regulates podocyte cell area changes induced
by PAN treatment
Digital phase contrast micrographs of transfectants
were analyzed to determine cell area by manually
outlining cell borders and integrating the enclosed
area. The mean cell area of vector control cells treated
with 1.25 g/ml PAN was significantly greater than
sham-treated cells whereas the mean cell area was
significantly smaller in vector cells treated with 5.0
g/ml PAN (Fig. 7A). There were no significant
changes in mean cell area in the sense clones after
treatment with 1.25 g/ml PAN whereas treatment
with 5.0 g/ml PAN caused a significant increase in cell
area in both clones (Fig. 7B). The changes in mean cell
area of antisense clone 9 in response to PAN treatment
were similar to the responses of vector control cells
whereas the area of clone 20 cells showed no significant
change after 1.25 g/ml PAN treatment and a signifi-
cant decrease after 5.0 g/ml PAN treatment.
When analyzed in aggregate, only sense clones dis-
played significant differences in mean cell area vs.
identically treated vector control cells. Sense clones
were significantly smaller than vector controls after 1.25
Figure 6. Hsp27 regulates both
the normal podocyte actin cy-
toskeleton and the changes in-
duced by PAN. Immunofluores-
cence micrographs of Texas red
phalloidin staining of actin fila-
ments in vector control (A–C),
hsp27 sense (D–F), and hsp27
antisense (G–I) transfectants
are shown after treatment for 7
days with 0 g/ml (A, D, G),
1.25 g/ml (B, E, H), or 5.0
g/ml (C, F, I) PAN. Micro-
graphs of only one clone each
of sense (clone 23) or antisense
(clone 9) transfectants are shown
but are representative of results
obtained with both clones. White
bar in lower right corner  40 .
Figure 7. Hsp27 regulates podocyte cell area
changes induced by PAN treatment. The
results of cell area determinations are shown
for differentiated podocytes stably trans-
fected with vector alone (A), hsp27 sense (B;
left barsclone 23, right barsclone 31),
and hsp27 antisense (C; left barsclone 9,
right barsclone 20) constructs after treat-
ment for 7 days with 0, 1.25, or 5 g/ml
PAN. Cell surface area for each cell type was
determined by outlining the edges of the 10
cells closest to the arbitrary upper right
corner and entirely within each of 6 ran-
domly selected images and calculating total
cell area from the number of pixels enclosed by the outlines (n60 (vector) or 120 (60 of each sense or antisense clone) cells
per group; x	se; *P  0.05, **P  0.01 vs. untreated control cells; P  0.01 vs. vector control cells).
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g/ml PAN treatment and significantly larger than
controls after treatment with 5.0 g/ml PAN (Fig. 7B
vs. A). These results together clearly indicated hsp27
was able to modulate PAN-induced changes in cultured
podocyte cell area.
PAN effects on cell morphology and actin
cytoskeleton are relatively podocyte specific
To determine the cell specificity of the effects of PAN
observed in murine podocytes, we treated both NIH-
3T3 fibroblasts and kidney MMC with various concen-
trations of PAN. We found that the morphology of both
MMC and NIH-3T3 cells was unaffected by culture in
the presence of 1.25 g/ml PAN (compare Fig. 8A, B
with C and D, respectively). Treatment of either cell
type with 5.0 g/ml PAN resulted in a more flattened
cell morphology (Fig. 8E, F) as well as partial disruption
of actin filaments and increased cell area (data not
shown), similar to the results observed in differentiated
podocytes after treatment with 1.25 g/ml PAN. The
retraction, detachment, and severe actin filament dis-
ruption observed in differentiated podocytes after treat-
ment with 5.0 g/ml PAN were observed in MMC cells
only after treatment with 25 g/ml PAN (Fig. 8G) and
in NIH-3T3 cells at a PAN concentration 25 g/ml
(Fig. 8H). These results suggest that differentiated,
cultured podocytes are specifically affected by concen-
trations of PAN that do not affect other cell types, in
agreement with the earlier observation that podocytes
derived from primary glomerular outgrowths are highly
sensitive to PAN treatment (32).
DISCUSSION
We previously reported that the small heat shock
protein hsp27 is present at high levels in the glomerular
podocyte and that hsp27 mRNA expression, protein
quantity, and protein phosphorylation are all increased
in the glomeruli of rats with PAN-induced NS (12). In
the present study, we tested the hypothesis that hsp27
has an important role in regulating normal podocyte
structure and the dramatic structural changes in podo-
cytes that occur during NS. To do this, we developed
cultured podocyte clones stably transfected with sense
and antisense hsp27 constructs and analyzed the effects
of altered hsp27 levels using a newly developed in vitro
model of PAN-induced podocyte injury.
These studies used cultured podocytes derived from
the ‘Immortomouse’, which conditionally expresses the
SV40 T-antigen to permit growth as ‘differentiated’
podocytes expressing differentiation-specific protein
markers and displaying a flattened morphology, distinc-
tive cellular processes, and a low cell proliferation rate
(25). Although these differentiated podocytes do not
form the extensive interdigitating networks of second-
ary cell processes spanned by slit membranes charac-
teristic of podocytes in vivo, they do have several
fundamental characteristics of in vivo podocytes that
were lacking in earlier podocyte culture systems; at this
time they represent the best available in vitro cell
culture system for analysis of podocyte responses to
relevant effectors such as PAN. We analyzed changes in
podocyte morphology and actin cytoskeleton after 7
days of PAN treatment, a time selected to closely model
the time of the most dramatic podocyte structural
changes in PAN-induced NS in vivo.
We found that this in vitro podocyte injury model
could reproducibly mimic many of the podocyte mor-
phological and actin cytoskeletal changes seen during
NS in vivo. These changes included alterations in cell
morphology and size, process retraction, and actin
filament disruption. In addition, the low-dose PAN
treatment induced significant hsp27 accumulation in
Figure 8. PAN does not affect MMC or NIH-3T3 cell mor-
phology or actin cytoskeleton. Phase contrast micrographs of
mouse mesangial cells (A, C, E, G) or NIH-3T3 cells (B, D, F,
H) treated for 7 days with 0 (A, B), 1.25 (C, D), 5.0 (E, F), or
25 (G, H) g/ml PAN. White bar in lower right corner 
40 .
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podocytes, similar to our earlier findings of glomerular
hsp27 accumulation in experimental NS in vivo, pro-
viding further validation of the in vitro model. Because
of these similarities, we believe this model has signifi-
cant potential to permit more mechanistic studies of
podocyte pathobiology during PAN-induced injury in
the future.
We tested several concentrations of PAN in this
treatment regime and discovered two distinct responses
of cultured murine podocytes at either a low (1.25
g/ml) or high (5 g/ml) concentration. Previously
described PAN treatments of cultured podocytes (32,
33) used higher PAN concentrations (50–100 g/ml)
over shorter periods (20–72 h) with results similar to
the response of vector control cells treated with 5.0
g/ml PAN for 7 days in this study. This response was
characterized by cell retraction, rounding, and detach-
ment, as well as disruption of the actin cytoskeleton.
Although treatment with 1.25 g/ml PAN for 7 days
also resulted in discernible rearrangements of actin
stress fibers, the number of live cells, the mean cell
area, and the F-actin content of these cells all actually
increased significantly, reflecting a fundamentally dis-
tinct biological response from that previously reported.
This reciprocal response of podocytes to low vs.
higher concentrations of PAN demonstrates that podo-
cytes can respond to a stressor with relevance to NS in
at least two distinct fashions: 1) by active processes such
as expansion of cell area, an increase in F-actin content,
and increased cell survival or proliferation, or 2) by
responses more characteristic of a toxic effect such as
cell process retraction, a decrease in F-actin content,
and decreased cell survival. We thus speculate that the
low-concentration PAN treatment regime may be more
relevant to podocyte changes that occur in typical
idiopathic NS in vivo, since little or no podocyte death
has been associated with this disease (34) and the
effacement observed in vivo is characterized by a loss of
distinctive foot process morphology and a decrease in
cell perimeter (35), but not by a radical reduction in
the podocyte area in contact with the GBM. In contrast,
the higher concentration PAN treatment regime may
be more relevant to podocyte changes that occur in
more resistant forms of NS, such as focal segmental
glomerulosclerosis, where more severe podocyte injury
and retraction may result in 1) detachment of foot
processes from the GBM and subsequent formation of
synechiae, 2) decreased podocyte survival that results in
podocyte loss in the urine (36), and ultimately 3)
development of chronic renal insufficiency.
We also found that alterations in hsp27 levels were
able to regulate a variety of podocyte characteristics in
the absence of any treatment. Hsp27 has been reported
by numerous investigators to have both positive and
negative roles in the regulation of actin filament dy-
namics. It has been identified as an barbed-end fila-
ment capping protein in vitro (37) and has been
reported to inhibit recovery of actin filaments and focal
adhesions induced by disruption via heat shock and to
delay reattachment and limit recovery of actin filaments
(23). In contrast to these negative effects, hsp27 has
also been reported to confer protection against actin
filament disruption caused by oxidants (38), to provide
partial protection against cell death caused by hydro-
gen peroxide treatment (38), and to suppress actin
filament disruption induced by cytochalasin D as well as
accelerating the reassembly of actin stress fibers (15,
39). Our results are entirely consistent with a protective
role for hsp27 in the regulation of actin filaments. We
found that modulation of hsp27 expression alone (in
the absence of PAN treatment) in podocytes consis-
tently resulted in morphological and actin cytoskeletal
alterations.
The effects of altered hsp27 phosphorylation on
podocyte morphology and actin cytoskeletal structure,
however, were less clear. Although the hsp27 sense cells
contained a larger amount of phosphorylated hsp27
than either the vector or antisense cells, they also had a
lower percentage of hsp27 phosphorylation than either
of the other cells. The relative biological importance of
the absolute amount vs. relative phosphorylation of
hsp27 is not yet understood, but hsp27 phosphorylation
itself is known to have important effects on hsp27
function. Phosphorylation has been shown to abolish
the ability of hsp27 to inhibit actin polymerization in
vitro (37) and to regulate the organization of hsp27
into multimers (40). Chinese hamster fibroblasts over-
expressing a nonphosphorylatable mutant hsp27 pro-
tein have been reported to have a reduced F-actin
content and a delay in growth factor-induced actin
polymerization (15), and actin filaments in these cells
were more sensitive to heat shock-induced disruption
(24). Although these studies made no attempt to
quantify the absolute or relative amounts of phosphor-
ylated hsp27 present in transfectants, they do suggest
that the amount of phosphorylated (or unphosphory-
lated) hsp27 present in cells may be a determining
factor in regulating actin filament structure by hsp27.
Our results can thus be interpreted in one of two ways:
that the quantity 1) of total hsp27 or 2) of either the un-
or monophosphorylated hsp27 isoform is primarily
responsible for the effects of hsp27 on podocyte mor-
phology and the actin cytoskeleton. However, since
both sense and antisense transfection resulted in less
relative phosphorylation of hsp27 than controls yet
displayed divergent and largely opposite effects on
podocytes, we conclude that differences in the relative
phosphorylation of hsp27 were not responsible for the
changes observed. Further studies to determine the
effects of stable expression of hsp27 mutant proteins
that are nonphosphorylatable or pseudo-phosphory-
lated are under way in our laboratory to clarify the role
of hsp27 phosphorylation on podocyte structure.
Our findings also demonstrated the ability of hsp27
to regulate a variety of cellular responses of podocytes
to PAN-induced injury. Podocyte hsp27 levels corre-
lated directly with resistance to PAN-induced cell death.
This finding is entirely consistent with hsp27’s known
chaperonin function (41, 42). Alternatively, although
we did not determine whether cell death was due to
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apoptosis vs. necrosis, this protection may have resulted
from hsp27’s reported role in protection against apo-
ptosis (43). Hsp27 was also able to regulate the podo-
cyte morphological and actin cytoskeletal responses to
PAN. Compared with the morphological changes and
quantitative and qualitative disruption of actin fila-
ments seen in vector control cells, cells containing
greater amounts of hsp27 were markedly protected
whereas cells expressing lesser amounts of hsp27 were
markedly more sensitive to PAN-induced injury. Al-
though hsp27 has been reported to function as either a
chaperonin or regulator of the actin cytoskeleton, the
pronounced actin cytoskeletal effects seen in the cur-
rent studies suggest that hsp27’s major role in podo-
cytes is probably in the regulation of the actin cytoskel-
eton.
In summary, we analyzed murine podocytes stably
transfected with hsp27 sense, antisense, and vector
control constructs using a newly developed in vitro PAN
model system designed to mimic the podocyte struc-
tural changes seen in NS. We found that hsp27 is able
to regulate many key structural features of podocytes.
More importantly, we also found that hsp27 is able to
regulate the morphological and actin cytoskeletal re-
sponse of podocytes to injury induced by PAN, a toxic
compound used in a well-established in vivo model of
NS. In conjunction with our earlier findings of in-
creased glomerular hsp27 expression and phosphoryla-
tion during PAN-induced NS, these findings suggest
that hsp27 may have an important role in regulating
the podocyte structural changes observed during the
development of and/or recovery from nephrotic
syndrome.
This work was supported in part by National Institutes of
Health grant K08 DK02455–01 and a Research Grant from
the National Kidney Foundation of Michigan to W.E.S.
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